fr

Oncotarget Podcast

Oncotarget

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed. Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed. Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/

N'hésitez pas à visiter le site du podcast et à soutenir son créateur : www.oncotarget.com

Auteur

Oncotarget Podcast

Catégorie

Science

Site du podcast

www.oncotarget.com

Dernier épisode

20 oct. 2026

Où écouter ?

Les podcasts dans l'appli Replaio Radio Bientôt disponible

Les podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts

Télécharger sur Google Play Installe-la gratuitement Android près de 10 M de téléchargements · note de 4,8 iOS bientôt

Épisodes

Author Insight: Secretomes from Metastatic Breast Cancer Cells and MSC Actions 14.04.2022

Jonathan Kelber and Francesca Sanchez from the Department of Biology, California State University Northridge, Northridge CA, discuss a research paper they co-authored for Oncotarget in 2019, entitled, "Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung." DOI - https://do...

Paper Spotlight: Novel Therapeutic Strategies Against Endometrial Cancer 07.04.2022

Listen to a blog summary of a trending research paper published by Oncotarget in Volume 13, entitled, "Role of the prorenin receptor in endometrial cancer cell growth." _________________________________ In the United States and worldwide, the incidence and mortality rates of endometrial cancer among women have been increasing in recent years. While endometrial cancer is highly treatable, the prima...

Author Insight: Down Syndrome iPSC Model: Endothelial Perspective on Tumor Development 31.03.2022

Mariana Perepitchka, Yekaterina Galat, and Dr. Vasiliy Galat discuss their 2020 research paper published by Oncotarget, entitled, "Down syndrome iPSC model: endothelial perspective on tumor development." DOI - https://doi.org/10.18632/oncotarget.27712 Correspondence to - Mariana Perepitchka - mperepitchka@u.northwestern.edu, Yekaterina Galat - ygalat@luriechildrens.org, and Vasiliy Galat - v-galat...

Announcement: Impact Journals at AACR Annual Meeting 2022 28.03.2022

BUFFALO, NY-March 22, 2022 – Impact Journals publishes scholarly journals in biomedical sciences with a focus on all areas of cancer and aging research. Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) 2022 annual meeting from April 8-13, 2022, in New Orleans, Louisiana. This year, the AACR conference is entitled, “Decoding Cancer Complex...

Trending With Impact: Interrelated Oncogenic Pathways in Osteosarcoma 25.03.2022

Listen to a blog summary of a trending research paper published in Volume 13, entitled, “Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients.” __________________________ Osteosarcoma (OS) is a fairly uncommon type of bone cancer that primarily develops in the long bones found in the arms and legs. While most osteosarcomas occur in patient...

Trending With Impact: Adjunct Virotherapy Fights Multiple Myeloma 18.03.2022

Listen to a blog summary of a trending research paper published by Oncotarget in Volume 13, entitled, "Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma.“ ______________________ Multiple myeloma (MM) is a currently incurable cancer of blood plasma cells. Autologous stem cell transplantation (ASCT) has...

Paper Spotlight: Remote Weight Loss Strategy for Breast Cancer Survivors 10.03.2022

Listen to a blog summary of a trending editorial co-authored by researchers Jennifer Y. Sheng and Vered Stearns from Johns Hopkins School of Medicine and the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, entitled, "Innovating and expanding weight loss strategies for breast cancer survivors.” ___ After being diagnosed with breast cancer, up to 96% of women have reported gaining weight. M...

Trending With Impact: Are NOTCH1 Variants Prognostic in Breast Cancer? 24.02.2022

The genetic changes that occur within the protein-coding gene NOTCH1 have not yet been fully studied or classified. Despite a lack in research, previous studies have suggested that NOTCH1 may be a potential target for novel cancer therapies, particularly against triple-negative breast cancer (TNBC). NOTCH1 variants in TNBC tend to cluster in the PEST region and have previously been linked to gamma...

Author Insight: Mitigating Radiation for Space Colonization 23.02.2022

Franco Cortese from the Biogerontology Research Foundation, London, UK, details a review he co-authored that was published by Oncotarget in Volume 9, Issue 18, entitled, “Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization.” DOI - https://doi.org/10.18632/oncotarget.24461 Correspondence to - I...

Author Insight: Potential Protective Mechanism Against UVB Exposure 21.02.2022

Dr. Dae Joon Kim and Liza Morales from the Department of Biomedical Sciences, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX, detail a priority research paper they co-authored that was published by Oncotarget in Volume 8, Issue 53, entitled, “UVB-induced nuclear translocation of TC-PTP by AKT/14-3-3σ axis inhibits keratinocyte survival and proliferation.” DOI - https://doi...

Trending With Impact: New Pre-Transplant AML Treatment Combinations 18.02.2022

Acute myeloid leukemia (AML) is a cancer of the blood that begins in the bone marrow and progresses quickly if left untreated. AML can occur both in adults and children and is often treated with allogeneic hematopoietic stem cell transplantation (allo-HSCT). Allo-HSCT is a procedure that replaces stem cells that were damaged or destroyed after radiation and/or chemotherapy treatment with stem cell...

Author Insight: Cancer Drug Prices in Low- and Middle-Income Countries 15.02.2022

Dr. Bishal Gyawali from the Institute of Cancer Policy, London and Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, discusses an editorial he authored that was published by Oncotarget in Volume 8, Issue 52, entitled, “Cancer drugs in LMICs: cheap but unaffordable.” DOI - https://doi.org/10.18632/oncotarget.21976 (PDF download) Full text - https://www.oncotarget.com/art...

Paper Spotlight: Iron Chelators in Cancer Treatment 10.02.2022

Iron is essential for human life, however, this element can also become toxic in high doses. Contrary to iron anemia, iron overload occurs when the body accumulates more iron than it can use, and this excess iron is damaging to cells and tissues. Famous for their atypical growth patterns, cancer cells accumulate a surplus of iron to support their irregular growth and metabolism. Thus, the metaboli...

Author Insight: Precision Oncology Improves Patient Survival, Financial Burdens 08.02.2022

Dr. Derrick Haslem and Dr. Lincoln Nadauld from the Precision Genomics Program, Intermountain Healthcare, Saint George, UT, discuss a research paper they co-authored that was published by Oncotarget as the cover for Volume 9, Issue 15, entitled, “Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs.” DOI - https://doi.org/10.18632/oncotarget.2...

Paper Spotlight: Prognostic Markers Identified in Ultra-Rare Adrenal Cancer 02.02.2022

Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that forms in the outer layer of the adrenal gland tissue above the kidneys. According to the National Institutes of Health, the occurrence of ACC in the United States is believed to only affect one to two people per million, per year. This highly-rare disease also challenges patients and researchers due to its post-diagnosis five-year...

Trending With Impact: What Causes Chemo Brain? 02.02.2022

A type of mental fog—known as “chemo brain”—is widely experienced by patients who have undergone cancer treatment. Cancer research institutions define chemo brain as impaired cognition, including cloudiness, memory loss and/or lack of concentration, that occurs before, during and/or after cancer treatment. This condition can negatively impact quality of life in a significant way. Chemo brain not o...

Role of Cancer Associated Fibroblasts in Prostate Cancer 27.01.2022

Dr. Nerymar Ortiz-Otero from the Meinig School of Biomedical Engineering, Cornell University, discusses a research paper she co-authored that was published by Oncotarget in Volume 11, Issue 12, entitled, “Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression.” DOI - https://doi.org/10.18632/oncotarget.27510 Correspondence to...

Oncotarget’s Top-10 Most-Viewed Papers in 2021 21.01.2022

Listen to a list of the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021. 10 - “Metformin and berberine, two versatile drugs in treatment of common metabolic diseases” DOI - https://doi.org/10.18632/oncotarget.20807 9 - “Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects” https://doi.org/10.18632/oncotarget.28088 8 - “Physi...

Rare Incidence of Type 1 Diabetes Induced by Immunotherapy 18.01.2022

Dr. Sandip Pravin Patel, Dr. Karen Yun and Dr. Karen Mccowen from the University of California San Diego, discuss a research paper they co-authored that was published by Oncotarget in Volume 11, Issue 28, entitled, “Rapid onset type 1 diabetes with anti-PD-1 directed therapy.” DOI - https://doi.org/10.18632/oncotarget.27665 Correspondence to - Sandip Pravin Patel - patel@ucsd.edu Abstract Type 1 d...

Microbial Metabolite Mimicry May Improve Drug Discovery 17.01.2022

Dr. Sridhar Mani from Medicine and Genetics of The Albert Einstein College of Medicine, Bronx, NY, details his editorial published by Oncotarget in Volume 11, Issue 19, entitled, “Microbial metabolite mimicry: one step closer to drug discovery.” DOI - https://doi.org/10.18632/oncotarget.27591 Correspondence to - Sridhar Mani - sridhar.mani@einsteinmed.org Sign up for free Altmetric alerts about th...

Gene Mutations and Neoantigens in Head and Neck Tumors 14.01.2022

Head and neck cancer is a group of various tumors located in the oral cavity, oropharynx, larynx, and hypopharynx. Head and neck cell squamous-cell carcinomas (HNSCC) often result from tobacco use or human papillomavirus (HPV+) infection. In locally advanced HNSCC, the current therapies used are combined surgery, radiotherapy and chemotherapy. Despite the use of traditional treatments, up to 50% o...

Announcement: Open-Access Oncotarget Shifts to Continuous Publishing 06.01.2022

BUFFALO, NY, January 6, 2022 – Since its inception in 2010, Oncotarget has operated as a traditional-style journal that publishes online page numbered issues of peer-reviewed papers. Final paginated issues were then released in their permanent form to Pubmed. As of 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in thei...

New Study: Biomarkers Linked to the Progression of Endometrial Cancer 24.12.2021

Statistics from the American Cancer Society indicate that endometrial cancer (EC) is on the rise among women in the United States. While it more commonly affects older women, researchers are finding that EC is the only gynecological cancer today increasing in incidence and mortality among younger women. Not to be confused with the benign condition of endometriosis, EC tumors are highly heterogeneo...

Functional Inhibitor Compounds Inhibit Herpes Simplex Virus Proliferation 23.12.2021

Oncotarget published "Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation" which reported that due to the small number of molecular targets in viruses and the rapid evolution of viral genes, it is very challenging to develop specific antiviral drugs. In addition, HIV-1 and Herpes Simplex virus are known to use IRES as w...

Unique Biomarker Analysis & Interpretation Platform in Clinical Decision-making 22.12.2021

The cover for issue 29 of Oncotarget features Figure 2, "Categorisation of samples analysed," from Laes, et al. - OncoDNA treatment recommendation followed in 60% of cases - 93% of treatment decisions were made based on a holistic approach combining next generation sequencing (NGS) and multiple biomarker analysis provided by OncoDNA - 27% of late-stage patients treated with OncoDNA-recommended the...

Écoute le podcast Oncotarget sur Replaio

La radio et les podcasts dans une seule appli - gratuite, sans inscription. Installe-la dès aujourd'hui et ne rate pas le lancement

Télécharger sur Google Play

Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics